Table 2 |
||||
| Disposition of study cases | ||||
| Parameter | Count | Reader A | Reader B | Reader C |
| n | n (%) | n (%) | n (%) | |
| Total number of tissue cores | 189 | |||
| Number of tissue cores without tumor | 6 | |||
| Number of cores with tumor | 183 | |||
| Number of cores with evaluable gene-protein IHC results | 183 (100.0) | 183 (100.0) | 183 (100.0) | |
| Number of cores with evaluable single IHC results | 183 (100.0) | 183 (100.0) | 183 (100.0) | |
| Number of cores with evaluable gene-protein BISH results | 179 (97.8) | 179 (97.8) | 180 (98.4) | |
| Number of cores with evaluable single BISH results | 166 (90.7) | 172 (94.0) | 173 (94.5) | |
IHC: immunohistochemistry; BISH: brightfield in situ hybridization.
Nitta et al. Diagnostic Pathology 2012 7:60 doi:10.1186/1746-1596-7-60
